Health · Pharma & Biotech · 1 day ago
More than 21,000 bottles of blood pressure medicine recalled
More than 21,000 bottles of a blood pressure medicine were recalled nationwide because they may contain too much telmisartan.
The medicine combines telmisartan 40 mg and amlodipine 5 mg, and was sold by prescription in 30-count bottles from Mylan Pharmaceuticals.
Five lots are affected: 3228113, 3228114 and 3228115, expiring October 31, 2026, and 3228120 and 3228121, expiring November 30, 2026.
The FDA classified the voluntary recall as Class III, meaning use of the medicine is not likely to cause adverse health consequences.
Check the lot number and expiry date on your prescription bottle to see if it is included.
If it is, stop taking it and contact your doctor or pharmacist; a pharmacy may offer a refund.
People with questions can contact the FDA by phone.
More than 21,000 bottles of a blood pressure medicine have been recalled nationwide because the tablets contain more telmisartan than specified.
The affected prescription medicine combines telmisartan 40 milligrams and amlodipine 5 milligrams.
The recalled bottles were distributed in 30-count containers by Mylan Pharmaceuticals Inc.
The FDA classified the voluntary recall as Class III, saying consumption is not likely to cause adverse health consequences.
People with affected bottles are advised to stop taking the medicine and consult a doctor or pharmacist.
- Who
- Mylan Pharmaceuticals Inc. distributed the medicine. The FDA classified the recall.
- What
- More than 21,000 bottles of a combination blood pressure medicine were recalled because the tablets contain excess telmisartan.
- When
- Not stated
- Where
- Nationwide in the United States.
- Why
- The telmisartan content exceeds specifications, making the medicine too potent.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Bottles recalled
- More than 21,000
- Medicine
- Telmisartan 40 milligrams and amlodipine 5 milligrams
- Distributor
- Mylan Pharmaceuticals Inc.
- Bottle size
- 30-count
- Affected lots
- 3228113, 3228114, 3228115, 3228120 and 3228121
- FDA classification
- Class III
3 sources
What people are saying
is not likely to cause adverse health consequences
superpotent drug